BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alisi A, de Vito R, Monti L, Nobili V. Liver fibrosis in paediatric liver diseases. Best Pract Res Clin Gastroenterol. 2011;25:259-268. [PMID: 21497743 DOI: 10.1016/j.bpg.2011.02.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Liu JQ, Chen WJ, Zhou MJ, Li WF, Tang J, Zhou QC. A Nomogram Predicting the Prognosis of Children With Biliary Atresia After Hepatoportoenterostomy. Front Pediatr 2021;9:641318. [PMID: 33718307 DOI: 10.3389/fped.2021.641318] [Reference Citation Analysis]
2 Weiss B, Krauthammer A, Soudack M, Lahad A, Sarouk I, Somech R, Heimer G, Ben-zeev B, Nissenkorn A. Liver Disease in Pediatric Patients With Ataxia Telangiectasia: A Novel Report. Journal of Pediatric Gastroenterology & Nutrition 2016;62:550-5. [DOI: 10.1097/mpg.0000000000001036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
3 Dong R, Zheng S. Interleukin-8: A critical chemokine in biliary atresia: Interleukin-8 in biliary atresia. J Gastroenterol Hepatol 2015;30:970-6. [DOI: 10.1111/jgh.12900] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
4 Hahn SM, Kim S, Park KI, Han SJ, Koh H. Clinical benefit of liver stiffness measurement at 3 months after Kasai hepatoportoenterostomy to predict the liver related events in biliary atresia. PLoS One. 2013;8:e80652. [PMID: 24260445 DOI: 10.1371/journal.pone.0080652] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
5 Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol 2012;33:1001-12. [PMID: 22534759 DOI: 10.1007/s00246-012-0315-7] [Cited by in Crossref: 206] [Cited by in F6Publishing: 163] [Article Influence: 20.6] [Reference Citation Analysis]
6 Halim MH, Abdulla NA, Kamel A, El Maksoud NA, Ragab HM. Significance of growth differentiation factor 15 in chronic HCV patients. J Genet Eng Biotechnol. 2017;15:403-407. [PMID: 30647678 DOI: 10.1016/j.jgeb.2017.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gao F, Chen YQ, Fang J, Gu SL, Li L, Wang XY. Acoustic Radiation Force Impulse Imaging for Assessing Liver Fibrosis Preoperatively in Infants With Biliary Atresia: Comparison With Liver Fibrosis Biopsy Pathology. J Ultrasound Med 2017;36:1571-8. [PMID: 28407283 DOI: 10.7863/ultra.16.08043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X, Cheng M, Si Y, Wang M, Zhong J, Niu J, Yang W. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. PLoS One. 2015;10:e0127518. [PMID: 25996938 DOI: 10.1371/journal.pone.0127518] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
9 Shang S, Cao Q, Han X, Wang Y, Yin C, Zhao L. Assessing Liver Hemodynamics in Children With Cholestatic Cirrhosis by Use of Dual-Energy Spectral CT. AJR Am J Roentgenol 2020;214:665-70. [PMID: 31967500 DOI: 10.2214/AJR.19.22035] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Keller LM, Eighmy S, Li C, Winter L, Kerecman J, Goodman Z, Mittal N, Blanco CL. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp. PLoS One 2020;15:e0228985. [PMID: 32150543 DOI: 10.1371/journal.pone.0228985] [Reference Citation Analysis]
11 AlKhater SA. Paediatric non-alcoholic fatty liver disease: an overview. Obes Rev 2015;16:393-405. [PMID: 25753407 DOI: 10.1111/obr.12271] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
12 Yang LY, Fu J, Peng XF, Pang SY, Gao KK, Chen ZR, He LJ, Wen Z, Wang H, Li L, Wang FH, Yu JK, Xu Y, Gong ST, Xia HM, Liu HY. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia. World J Gastroenterol 2015; 21(19): 5893-5900 [PMID: 26019453 DOI: 10.3748/wjg.v21.i19.5893] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
13 He L, Ip DKM, Tam G, Lui VCH, Tam PKH, Chung PHY. Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis. Sci Rep 2021;11:11692. [PMID: 34083585 DOI: 10.1038/s41598-021-91072-y] [Reference Citation Analysis]
14 Liu L, Wang J, Feng J, Yao M, Hao C, You Y, Yan Y, Gong J, Lu Y, Xie X, Zhang M, Chen L, Li T, Lu F, Wang JS. Serum Golgi protein 73 is a marker comparable to APRI for diagnosing significant fibrosis in children with liver disease. Sci Rep 2018;8:16730. [PMID: 30425268 DOI: 10.1038/s41598-018-34714-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Nobili V, Svegliati-baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: Recent insights. Journal of Hepatology 2013;58:1218-29. [DOI: 10.1016/j.jhep.2012.12.003] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 11.8] [Reference Citation Analysis]
16 Wang S, Wang JQ, Lv XW. Exosomal miRNAs as biomarkers in the diagnosis of liver disease. Biomark Med 2017;11:491-501. [PMID: 28598214 DOI: 10.2217/bmm-2017-0011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
17 de Magnée C, Veyckemans F, Pirotte T, Menten R, Dumitriu D, Clapuyt P, Carbonez K, Barrea C, Sluysmans T, Sempoux C, Leclercq I, Zech F, Stephenne X, Reding R. Liver and systemic hemodynamics in children with cirrhosis: Impact on the surgical management in pediatric living donor liver transplantation. Liver Transpl 2017;23:1440-50. [DOI: 10.1002/lt.24850] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]